Tech News
← Home  ·  All topics

Calytrix Bio

1 GoKawiil brief on this topic · RSS for calytrix bio

Eli Lilly Agrees to Acquire Calytrix Bio in Deal Worth Up to $1.5 Billion

Eli Lilly announced it will acquire Calytrix Bio, a privately held biotech backed by JPMorgan Chase, in a deal valued at up to $1.5 billion. Calytrix is developing treatments targeting a set of rare blood cancers.